Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.84 AUD
Change Today +0.015 / 1.83%
Volume 65.6K
As of 12:10 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Katherine A. High M.D.

Former Member of Scientific Advisory Board, Benitec Biopharma Limited
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 6 different industries.

See Board Relationships


Dr. Katherine A. High, also known as Kathy, M.D. has been President and Chief Scientific Officer at Spark Therapeutics, Inc. since September 16, 2014. Dr. High serves as Scientific Co-Founder and Advisor at Spark Therapeutics, Inc. (a/k/a, Spark Therapeutics, LLC). She began her career the molecular basis of blood coagulation and the development of novel therapeutics for the treatment of bleeding disorders studies. Her work has evolved to encompass clinical translation ...

Read Full Background

Corporate Headquarters*

F6A/1-15 Barr Street
Sydney, New South Wales 2041


Phone: 61 2 9555 6986
Fax: 61 2 9818 2238

Board Members Memberships*

Co-Founder, President, Chief Scientific Officer, Director and Chairman of Science & Technology Committee


Harvard University
University of North Carolina at Chapel Hill School of Medicine
Master's Degree
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Total Annual Compensation$108,538

Stock Options*

Restricted Stock Awards$467,966
All Other Compensation$8,169
Unexercisable Options158,249
Unexercisable Options Value$1,986,025
Total Value of Options$1,986,024
Total Number of Options158,249

Total Compensation*

Total Annual Cash Compensation$162,603
Total Short Term Compensation$108,538
Other Long Term Compensation$476,135
Total Calculated Compensation$630,569
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLT:AU A$0.84 AUD +0.015


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BENITEC BIOPHARMA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at